I. Wijting

发表

Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy

P. Reiss, W. Bierman, F. Wit, 2019, EClinicalMedicine.

Changes in renal, bone, lipid, and inflammation markers in HIV-1 patients after combination antiretroviral therapy simplification to dolutegravir monotherapy

W. Bierman, M. Zillikens, H. Bax, 2019, International journal of STD & AIDS.

HIV Treatment Strategies – The role of integrase strand transfer inhibitors

I. Wijting, 2019 .

Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial.

Eleni-Rosalina Andrinopoulou, Bart Rijnders, E. Andrinopoulou, 2017, The lancet. HIV.

Reply to Darcis and Berkhout.

C. Boucher, H. Pham, D. A. van de Vijver, 2018, The Journal of infectious diseases.

HIV-1 Resistance Dynamics in Patients With Virologic Failure to Dolutegravir Maintenance Monotherapy

C. Boucher, H. Pham, D. A. van de Vijver, 2018, The Journal of infectious diseases.

Chapter 3 HIV-1 resistance dynamics in patients with virological failure to dolutegravir maintenance monotherapy .

C. Boucher, R. Schuurman, T. Mesplède, 2018 .

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer Inhibitors

M. Wainberg, B. Brenner, C. Boucher, 2018, The Journal of infectious diseases.

Chapter 2 Dolutegravir as maintenance monotherapy for HIV ( DOMONO ) : a phase 2 , randomised non-inferiority trial

C. Boucher, W. Bierman, H. Bax, 2018 .

Predictors of virological failure in HIV‐1‐infected patients switching to dolutegravir maintenance monotherapy

C. Boucher, C. Boucher, L. Vandekerckhove, 2018, HIV medicine.